Abstract
Multiple sclerosis results from the failure of several different regulatory mechanisms designed to protect against autoimmunity, suggesting multiple targets for therapeutic intervention. Three papers in this issue suggest that if tolerance to components of the nervous system is not maintained in the thymus and autoimmunity ensues, the extent of brain damage can be checked by blockade of glutamate receptors on neurons and oligodendrocytes (56–70).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Steinman, L. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system. Cell 85, 299– 302 (1996).
Klein, L., Klugmann, M., Nave, K., Tuohy, V. & Kyewski, B. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nature Med. 6, 56–61 ( 2000).
Pitt D., Werner, P. & Raine, C. Glutamate excitotoxicity as a mechanism in multiple sclerosis . Nature Med. 6, 67–70 (2000).
Smith, T., Groom, A., Zhu, B. & Turski, L. Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nature Med. 6, 62–66 (2000).
Pribyl, T.M., Campagnoni, C., Kampf, K., Handley, V.W. & Campangnoni, A.T. The major myelin protein genes are expressed in the human thymus. J. Neurosci. Res. 45, 812–819 (1996).
Haines, J.L. et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. The Multiple Sclerosis Genetics Group. Nature Genet. 13, 469– 471 (1996)
Ebers, G.C. et al. A full genome search in multiple sclerosis [see comments] . Nature Genet. 13, 472– 476 (1996).
Sawcer, S. et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 [see comments]. Nat. Genet. 13, 464–468 (1996).
Steinman, L. Assessment of the utility of animal models for multiple sclerosis and demyelinating disease in the design of rational therapy. Neuron 24 , 511–514 (1999).
Trapp, B.D. et al. Axonal transection in the lesions of multiple sclerosis. N. Eng. J. Med. 338, 278–285 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Steinman, L. Multiple approaches to multiple sclerosis. Nat Med 6, 15–16 (2000). https://doi.org/10.1038/71466
Issue Date:
DOI: https://doi.org/10.1038/71466
This article is cited by
-
Dynamics of the meningeal CD4+ T-cell repertoire are defined by the cervical lymph nodes and facilitate cognitive task performance in mice
Molecular Psychiatry (2014)
-
Purely systemically active anti-inflammatory treatments are adequate to control multiple sclerosis
Journal of Neurology (2005)
-
Alternatives to current disease-modifying treatment in MS: what do we need and what can we expect in the future?
Journal of Neurology (2004)
-
An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide
Nature Immunology (2001)
-
Neuroprotective autoimmunity—a double-edged sword?
Nature Medicine (2000)
